Xenon Pharmaceuticals, Inc. (XENE)
54.17
+0.05
(+0.09%)
USD |
NASDAQ |
May 22, 16:00
54.16
-0.01
(-0.02%)
After-Hours: 20:00
Xenon Pharmaceuticals Free Cash Flow : -307.84M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals, Inc. | 166.93M |
| Alkermes Plc | 221.80M |
| Edesa Biotech, Inc. | -7.722M |
| ProMIS Neurosciences, Inc. | -35.63M |
| Tyra Biosciences, Inc. | -102.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -88.90M |
| Cash from Investing (Quarterly) | -407.28M |
| Cash from Financing (Quarterly) | 843.01M |
| Free Cash Flow Per Share (Quarterly) | -1.019 |
| Free Cash Flow to Equity (Quarterly) | -88.58M |
| Free Cash Flow to Firm (Quarterly) | -89.03M |
| Free Cash Flow Yield | -6.98% |